Banque Pictet & Cie’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-75,585
Closed -$741K 524
2023
Q1
$741K Sell
75,585
-34,268
-31% -$366K 0.01% 416
2022
Q4
$1.17M Sell
109,853
-34,661
-24% -$403K 0.01% 382
2022
Q3
$1.51M Buy
144,514
+16,783
+13% +$219K 0.02% 332
2022
Q2
$1.61K Buy
127,731
+26,689
+26% +$283K 0.02% 344
2022
Q1
$1.09M Buy
+101,042
New +$1.23M 0.01% 432

Other funds holding DVAX

Banque Pictet & Cie's DVAX Position: Q2 2023 in Review

Banque Pictet & Cie sold out of Dynavax Technologies (DVAX) in Q2 2023, closing a stake of 75,585 shares — an estimated $741K sold.

Banque Pictet & Cie first reported a position in DVAX in Q1 2022 and held it in 5 quarters. The position peaked at $1.51M in Q3 2022. 215 funds tracked by Wall St. Rank hold DVAX as of Q2 2023.

  • Banque Pictet & Cie reported no remaining Dynavax Technologies position as of Q2 2023 after selling out during the quarter.
  • Banque Pictet & Cie sold 75,585 Dynavax Technologies shares in Q2 2023, an estimated $741K.
  • Banque Pictet & Cie first reported a position in Dynavax Technologies in Q1 2022 and held it in 5 quarters.
  • Banque Pictet & Cie's Dynavax Technologies position peaked at $1.51M in Q3 2022.
  • 215 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2023.

Based on Banque Pictet & Cie's 13F filing for Q2 2023, filed 4 Aug 2023.